Stock Market news at lse.co.uk - RSS News Feeds

Lombard Med.tec Share News (LMT)



Share News for Lombard Med.tec (LMT)


Share Price: 184.50Bid: 182.00Ask: 187.00Change: 0.00 (0.00%)No Movement on Lombard Med.tec
Spread: 5.00Spread as %: 2.75%Open: 184.50High: 183.00Low: 183.00Yesterday’s Close: 184.50






Lombard Medical says implants Aorfix endovascular stent in Brazil

LONDON (Thomson Financial) - Lombard Medical Technologies PLC said its Aorfix endovascular stent graft has been implanted in Brazil for the firs
[22 May '07]

Lombard Medical files IDE supplement to FDA to widen Aorfix US clinical trial

LONDON (Thomson Financial) - Lombard Medical Technologies PLC said it has filed a supplement to its investigational device exemption (IDE) appli
[23 Apr '07]

Lombard Medical gets US FDA nod to use improved Aorfix stent graft in trial

LONDON (AFX) - Lombard Medical Technologies PLC said it has received US Food and Drug Administration approval to use an improved version of its
[4 Apr '07]

Lombard Medical sells 3.2 pct stake in Endoart for 3.2 mln usd

LONDON (AFX) - Lombard Medical Technologies PLC said it is selling its 3.2 pct shareholding in Swiss medical technology company Endoart for 3.2
[22 Feb '07]

Lombard Medical says Aorfix stent graft implanted in over 200 patients

LONDON (AFX) - Lombard Medical Technologies PLC said its Aorfix endovascular stent graft has been successfully implanted in over 200 patients.
[20 Feb '07]

Lombard Medical unit gets 88,000 stg grant for development of catheter coating

LONDON (AFX) - Lombard Medical Technologies PLC said its Polymer Coatings Division has received a 88,000 stg grant from the regional development
[12 Feb '07]

Lombard Medical says clinical cases of Aorfix graft 'highly successful'

LONDON (AFX) - Lombard Medical Technologies PLC said the first two clinical cases after restarting European clinical procedures involving its Ge
[5 Feb '07]

Lombard Medical to restart European clinical procedures for Aorfix graft Jan 31

LONDON (AFX) - Lombard Medical Technologies PLC said it is restarting European clinical procedures involving its Generation II Aorfix endovascul
[30 Jan '07]



Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.